BridgeMD
Compares treatment options for Lung Neoplasms
Official title Mediastinal Lymph Node Dissection Versus Spared Mediastinal Lymph Node Dissection in Stage I GGN NSCLC
ClinicalTrials.gov ID: NCT04631770
What this study is testing
- What it's testing
- Lung cancer is the leading cause of cancer related death worldwide. Lobectomy or sub-lobectomy with mediastinal lymph node dissection is the standard surgery.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- Thin-slice HRCT shows single GGN with C/T ≤ 0.5 and no lymph node metastasis;
- Clinical stage IA NSCLC (TNM 8th classification) diagnosed prior or in surgery;
- No history of malignancies within past 5 years or lung surgery;
- No anti-cancer treatment prior to surgery.
You likely can't join if
- Simultaneous or metachronous (within the past 5 years) double cancers;
- Active bacterial or fungous infection;
- Interstitial pneumonitis, pulmonary fibrosis, or severe pulmonary emphysema;
- Systemic steroidal medication;
- Uncontrollable diabetes mellitus; (vi) Uncontrollable hypertension or history of severe heart disease, heart failure.
The study team makes the final eligibility decision.
Where it's taking place
- Tianjin, Tianjin Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tianjin, Tianjin Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.